EXOSYSTEMS Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $6.54M

  • Investors
  • 13

EXOSYSTEMS General Information

Description

Developer of a digital healthcare company designed to provide AI-powered care for musculoskeletal and neuromuscular health. The company's platform offers wearable medical devices that collect muscle biosignals, AI-driven analysis for personalized rehabilitation, and remote therapeutic monitoring, enabling patients and healthcare providers to manage musculoskeletal disorders effectively and efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 803, 8th floor, Building A, 43 Changup-ro
  • Sujeong-gu, (Siheung-dong, Pangyo Global Biz Center)
  • Seongnam, Gyeonggi 13449
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Corporate Office
  • Room 803, 8th floor, Building A, 43 Changup-ro
  • Sujeong-gu, (Siheung-dong, Pangyo Global Biz Center)
  • Seongnam, Gyeonggi 13449
  • South Korea
+82

EXOSYSTEMS Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EXOSYSTEMS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC (Series B) 28-Jun-2026 $6.54M Completed Generating Revenue
15. Secondary Transaction - Private Completed Generating Revenue
14. Later Stage VC 31-Dec-2025 Completed Generating Revenue
13. Accelerator/Incubator 17-Jun-2025 Completed Generating Revenue
12. Grant 01-Apr-2022 Completed Startup
11. Early Stage VC (Series A) 29-Sep-2021 Completed Startup
10. Grant 01-Apr-2021 Completed Startup
9. Grant 01-Sep-2020 Completed Startup
8. Angel (individual) 24-Feb-2020 $40K $341K Completed Startup
7. Accelerator/Incubator 01-Jan-2020 $301K Completed Startup
To view EXOSYSTEMS’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EXOSYSTEMS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital healthcare company designed to provide AI-powered care for musculoskeletal and neuromuscular heal
Diagnostic Equipment
Seongnam, South Korea
26 As of 2026

New York, NY
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EXOSYSTEMS Competitors (2)

One of EXOSYSTEMS’s 2 competitors is Kaia Health, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kaia Health Formerly VC-backed New York, NY
Hinge Health Formerly VC-backed San Francisco, CA
You’re viewing 2 of 2 competitors. Get the full list »

EXOSYSTEMS Patents

EXOSYSTEMS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260182928-A1 Method and device for performing neuromuscular signal analysis Pending 27-Oct-2023
WO-2025089740-A1 Method and device for performing neuromuscular signal analysis Inactive 27-Oct-2023
US-20240207612-A1 Diagnosis system for sarcopenia and functional electrical stimulation therapy system using electromyography signal Pending 07-May-2021
WO-2022235129-A1 Sarcopenia diagnosis system and functional electrical stimulation treatment system using electromyographic signal Inactive 07-May-2021
WO-2020027360-A1 Rehabilitation system for executing rehabilitation program by using wearable device and user electronic device Inactive 02-Aug-2018 G16H40/67
To view EXOSYSTEMS’s complete patent history, request access »

EXOSYSTEMS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EXOSYSTEMS Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daewoong Pharmaceutical Corporation Minority
KDB Capital PE/Buyout Minority
Naver Corporation Minority
Sage One Partners Venture Capital Minority
PharmStars Accelerator/Incubator
You’re viewing 5 of 13 investors. Get the full list »

EXOSYSTEMS FAQs

  • When was EXOSYSTEMS founded?

    EXOSYSTEMS was founded in 2017.

  • Where is EXOSYSTEMS headquartered?

    EXOSYSTEMS is headquartered in Seongnam, South Korea.

  • What is the size of EXOSYSTEMS?

    EXOSYSTEMS has 26 total employees.

  • What industry is EXOSYSTEMS in?

    EXOSYSTEMS’s primary industry is Diagnostic Equipment.

  • Is EXOSYSTEMS a private or public company?

    EXOSYSTEMS is a Private company.

  • What is EXOSYSTEMS’s current revenue?

    The current revenue for EXOSYSTEMS is .

  • How much funding has EXOSYSTEMS raised over time?

    EXOSYSTEMS has raised $18M.

  • Who are EXOSYSTEMS’s investors?

    Daewoong Pharmaceutical, KDB Capital, Naver, Sage One Partners, and PharmStars are 5 of 13 investors who have invested in EXOSYSTEMS.

  • Who are EXOSYSTEMS’s competitors?

    Kaia Health and Hinge Health are competitors of EXOSYSTEMS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process